Literature DB >> 32840064

Persistent Bacteriuria and Antibodies Recognizing Curli/eDNA Complexes From Escherichia coli Are Linked to Flares in Systemic Lupus Erythematosus.

Ryan J Pachucki1, Chelsea Corradetti1, Lynne Kohler1, Jay Ghadiali1, Paul M Gallo1, Lauren Nicastro1, Sarah A Tursi1, Stefania Gallucci1, Çagla Tükel1, Roberto Caricchio1.   

Abstract

OBJECTIVE: Infections contribute to morbidity and mortality in systemic lupus erythematosus (SLE). Uropathogenic Escherichia coli (UPEC) are known to trigger urinary tract infections (UTIs) and form biofilms, which are multicellular communities of bacteria that are strengthened by amyloids such as curli. We previously reported that curli naturally form complexes with bacterial extracellular DNA (eDNA), and these curli/eDNA complexes induce hallmark features of lupus in mouse models. The present study was undertaken to investigate whether anti-curli/eDNA complex antibodies play a role in the pathogenesis of SLE or development of flares in SLE.
METHODS: In total, 96 SLE patients who met at least 4 Systemic Lupus International Collaborating Clinics disease criteria were investigated. Anti-curli/eDNA complex antibodies in the plasma were tested for both IgG and IgA subclasses. Results were compared to that in 54 age-, sex-, and race/ethnicity-matched healthy controls. Correlations of the levels of anti-curli/eDNA antibodies with clinical parameters, lupus disease status, and frequency of bacteriuria were assessed.
RESULTS: Anti-curli/eDNA antibodies were detected in the plasma of SLE patients and healthy controls, and their levels correlated with the presence of asymptomatic persistent bacteriuria and occurrence of disease flares in lupus patients. Persistent bacteriuria contained curli-producing UPEC, and this was associated with an inflammatory phenotype. Finally, curli/eDNA complexes cross-reacted with lupus autoantigens, such as double-stranded DNA, in binding autoantibodies.
CONCLUSION: These results suggest that UTIs and persistent bacteriuria are environmental triggers of lupus and its flares. Antibodies against curli/eDNA could serve as a sign of systemic exposure to bacterial products in SLE.
© 2020, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32840064      PMCID: PMC7722165          DOI: 10.1002/art.41400

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  34 in total

1.  Role of Escherichia coli curli operons in directing amyloid fiber formation.

Authors:  Matthew R Chapman; Lloyd S Robinson; Jerome S Pinkner; Robyn Roth; John Heuser; Marten Hammar; Staffan Normark; Scott J Hultgren
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

2.  The binding of sera of patients with SLE to bacterial and mammalian DNA.

Authors:  Kimberly J Hamilton; Georg Schett; Charles F Reich; Josef S Smolen; David S Pisetsky
Journal:  Clin Immunol       Date:  2005-11-18       Impact factor: 3.969

3.  Thin, aggregative fimbriae mediate binding of Salmonella enteritidis to fibronectin.

Authors:  S K Collinson; P C Doig; J L Doran; S Clouthier; T J Trust; W W Kay
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

4.  Epidemiology and clinical outcomes of bloodstream infections among lupus patients.

Authors:  M Marcos; C Fernández; A Soriano; F Marco; J A Martínez; M Almela; R Cervera; J Mensa; G Espinosa
Journal:  Lupus       Date:  2011-06-09       Impact factor: 2.911

Review 5.  Curli biogenesis and function.

Authors:  Michelle M Barnhart; Matthew R Chapman
Journal:  Annu Rev Microbiol       Date:  2006       Impact factor: 15.500

6.  Effectiveness and safety of belimumab in patients with systemic lupus erythematosus in a real-world setting.

Authors:  C Anjo; J-M Mascaró; G Espinosa; R Cervera
Journal:  Scand J Rheumatol       Date:  2019-07-02       Impact factor: 3.641

7.  Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2.

Authors:  Cagla Tükel; R Paul Wilson; Jessalyn H Nishimori; Milad Pezeshki; Brett A Chromy; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

Review 8.  Curli-Containing Enteric Biofilms Inside and Out: Matrix Composition, Immune Recognition, and Disease Implications.

Authors:  Sarah A Tursi; Çagla Tükel
Journal:  Microbiol Mol Biol Rev       Date:  2018-10-10       Impact factor: 11.056

9.  Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9.

Authors:  Sarah A Tursi; Ernest Y Lee; Nicole J Medeiros; Michael H Lee; Lauren K Nicastro; Bettina Buttaro; Stefania Gallucci; Ronald Paul Wilson; Gerard C L Wong; Çagla Tükel
Journal:  PLoS Pathog       Date:  2017-04-14       Impact factor: 6.823

10.  Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

Authors:  Ian N Bruce; Aidan G O'Keeffe; Vern Farewell; John G Hanly; Susan Manzi; Li Su; Dafna D Gladman; Sang-Cheol Bae; Jorge Sanchez-Guerrero; Juanita Romero-Diaz; Caroline Gordon; Daniel J Wallace; Ann E Clarke; Sasha Bernatsky; Ellen M Ginzler; David A Isenberg; Anisur Rahman; Joan T Merrill; Graciela S Alarcón; Barri J Fessler; Paul R Fortin; Michelle Petri; Kristjan Steinsson; Mary Anne Dooley; Munther A Khamashta; Rosalind Ramsey-Goldman; Asad A Zoma; Gunnar K Sturfelt; Ola Nived; Cynthia Aranow; Meggan Mackay; Manuel Ramos-Casals; Ronald F van Vollenhoven; Kenneth C Kalunian; Guillermo Ruiz-Irastorza; Sam Lim; Diane L Kamen; Christine A Peschken; Murat Inanc; Murray B Urowitz
Journal:  Ann Rheum Dis       Date:  2014-05-16       Impact factor: 19.103

View more
  8 in total

1.  Phenol-Soluble Modulins From Staphylococcus aureus Biofilms Form Complexes With DNA to Drive Autoimmunity.

Authors:  Kaitlyn Grando; Lauren K Nicastro; Sarah A Tursi; Jaime De Anda; Ernest Y Lee; Gerard C L Wong; Çağla Tükel
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

2.  Promise and complexity of lupus mouse models.

Authors:  Erica Moore; Joshua A Reynolds; Anne Davidson; Stefania Gallucci; Laurence Morel; Deepak A Rao; Howard A Young; Chaim Putterman
Journal:  Nat Immunol       Date:  2021-06       Impact factor: 31.250

Review 3.  Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases.

Authors:  Amanda L Miller; Shingo Bessho; Kaitlyn Grando; Çagla Tükel
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 4.  Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies.

Authors:  Quanren Pan; Fengbiao Guo; Yanyan Huang; Aifen Li; Shuxian Chen; Jiaxuan Chen; Hua-Feng Liu; Qingjun Pan
Journal:  Front Immunol       Date:  2021-12-03       Impact factor: 7.561

5.  Assembly of ordered DNA-curli fibril complexes during Salmonella biofilm formation correlates with strengths of the type I interferon and autoimmune responses.

Authors:  Lauren K Nicastro; Jaime de Anda; Neha Jain; Kaitlyn C M Grando; Amanda L Miller; Shingo Bessho; Stefania Gallucci; Gerard C L Wong; Çagla Tükel
Journal:  PLoS Pathog       Date:  2022-08-16       Impact factor: 7.464

Review 6.  B Cells and Microbiota in Autoimmunity.

Authors:  María Botía-Sánchez; Marta E Alarcón-Riquelme; Georgina Galicia
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 7.  Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.

Authors:  Stefania Gallucci; Sowmya Meka; Ana M Gamero
Journal:  Cytokine       Date:  2021-07-30       Impact factor: 3.926

8.  Context-dependent induction of autoimmunity by TNF signaling deficiency.

Authors:  Tam D Quach; Weiqing Huang; Ranjit Sahu; Catherine Mm Diadhiou; Chirag Raparia; Roshawn Johnson; Tung Ming Leung; Susan Malkiel; Peta Gay Ricketts; Stefania Gallucci; Çagla Tükel; Chaim O Jacob; Martin L Lesser; Yong-Rui Zou; Anne Davidson
Journal:  JCI Insight       Date:  2022-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.